AP2001002354A0 - Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses. - Google Patents

Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses.

Info

Publication number
AP2001002354A0
AP2001002354A0 APAP/P/2001/002354A AP2001002354A AP2001002354A0 AP 2001002354 A0 AP2001002354 A0 AP 2001002354A0 AP 2001002354 A AP2001002354 A AP 2001002354A AP 2001002354 A0 AP2001002354 A0 AP 2001002354A0
Authority
AP
ARIPO
Prior art keywords
interleukin
receptor
infections
prevention
treatment
Prior art date
Application number
APAP/P/2001/002354A
Inventor
Pierre- Francois Serres
Original Assignee
Hippocampe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hippocampe filed Critical Hippocampe
Publication of AP2001002354A0 publication Critical patent/AP2001002354A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention concerns the use of antibodies, or analogues blocking the interleukin-2 receptor which prevents the aids virus from fixing itself on its target cells and/orfrom penetrating into said cells. The invention is useful for treating hiv infections.
APAP/P/2001/002354A 1999-05-21 2000-05-22 Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses. AP2001002354A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9906528A FR2793691B1 (en) 1999-05-21 1999-05-21 USE OF ANTIBODIES RECOGNIZING THE INTERLEUKIN-2 RECEPTOR IN THE PREVENTION AND / OR TREATMENT OF AIDS VIRUS INFECTIONS
PCT/FR2000/001399 WO2000071159A1 (en) 1999-05-21 2000-05-22 Use of antibodies identifying the interleukin-2 receptor for preventing and/or treating hiv infections

Publications (1)

Publication Number Publication Date
AP2001002354A0 true AP2001002354A0 (en) 2001-12-31

Family

ID=9545913

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002354A AP2001002354A0 (en) 1999-05-21 2000-05-22 Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses.

Country Status (8)

Country Link
EP (1) EP1178827A1 (en)
AP (1) AP2001002354A0 (en)
AU (1) AU4930300A (en)
CA (1) CA2373991A1 (en)
EA (1) EA200101228A1 (en)
FR (1) FR2793691B1 (en)
OA (1) OA12311A (en)
WO (1) WO2000071159A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1578397B1 (en) 2002-11-15 2012-12-26 Genmab A/S Human monoclonal antibodies against cd25

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3815472A1 (en) * 1988-05-06 1989-11-16 Centre Regional De Transfusion MONOCLONAL ANTICOERPER AND ITS USE
JPH024800A (en) * 1988-06-24 1990-01-09 Ube Ind Ltd Module for removing interleukin ii receptor and method for removing interleukin ii receptor using said module
HUT60768A (en) * 1990-03-16 1992-10-28 Sandoz Ag Process for producing cd25 fixing molecules
JPH05244982A (en) * 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd Humanized b-b10

Also Published As

Publication number Publication date
AU4930300A (en) 2000-12-12
OA12311A (en) 2006-05-12
CA2373991A1 (en) 2000-11-30
FR2793691B1 (en) 2003-10-03
EP1178827A1 (en) 2002-02-13
FR2793691A1 (en) 2000-11-24
EA200101228A1 (en) 2002-08-29
WO2000071159A1 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
DE69840383D1 (en) CTL EPITOPE OF EPSTEIN-BARR VIRUS
FR12C0004I1 (en)
HK1009980A1 (en) Method for selective inactivation of viral replication
PL354976A1 (en) Factor ix/factor ixa antibodies and antibody derivatives
WO2004028454A3 (en) 1, 3, 5-triazines for treatment of viral diseases
NO20051969L (en) Nucleoside derivatives for the treatment of hepatitis C virus infection.
ATE229945T1 (en) 1,3, 4-THIADIAZOLES SUITABLE FOR THE TREATMENT OF CMV INFECTIONS
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
WO2002092006A3 (en) Nucleic acid-based compounds and methods of use thereof
HUP0202502A2 (en) Peptides that block viral infectivity and methods of use thereof
EP1256348A4 (en) Remedies for hepatitis c
PT1242119E (en) COMBINATIONS FOR THE TREATMENT OF INFECTIONS BY DNA VIRUS INCLUDING AN ANSA DIURETIC AND CARDIOTONIC GLYCOSIDE
WO2007002639A3 (en) Non-nucleoside anti-hepacivirus agents and uses thereof
MY137620A (en) Therapeutic treatment
DE69738512D1 (en) EPSTEIN-BARR VIRUS TYPE B CTL EPITOPES
ZA991029B (en) Composition and methods for treatment of hiv infections.
WO1997025071A3 (en) Immunoconjugate for the treatment of aids
AP2001002354A0 (en) Use of antibodies recognizing the interleukin-2 receptor in the prevention and /or treatment of infections by the AIDS viruses.
PT1435991E (en) Use of aplidine for the treatment of pancreatic cancer
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
UA90477C2 (en) Methods for treating hepatitis c (variants)
EP0227604A3 (en) Use of oligopeptides in the treatment of viral infections
ATE253936T1 (en) GLUTATHIONE REDUCTASE FOR THE TREATMENT AND PROPHYLAXIS OF AIDS
ZA200205470B (en) Virus strains for the oncolytic treatment of cancer.
NZ512850A (en) Treatment of papillomavirus infections